Express Scripts Holding Co. (ESRX)

Check out top investors' recommendation for ESRX
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
N/A
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
N/A
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. The company’s PBM services comprise retail network pharmacy management; home delivery pharmacy; benefit design consultation; drug utilization review; drug formulary management, and compliance and therapy management programs; an array of Medicare Part D and Medicaid products; specialty pharmacy services, such as the distribution of fertility pharmaceuticals that require special handling or packaging; bio-pharma services, including reimbursement and logistics solutions; group purchasing organization administration services; consumer health and drug information services; and medicine and pharmacogenomics application services. It is also involved in the distribution of pharmaceuticals and medical supplies to providers and clinics; and development of scientific evidence to guide the use of medicines. Express Scripts Holding Company provides its PBM services to managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans, and government health programs; and specialty services to managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists, and others. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.
Sector:
Industry:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Glen Santangelo Credit Suisse Buy   Feb 28, '18       Feb 28, '19  N/A 
Brian Tanquilut Jefferies & Co. Buy   Feb 28, '18     91.00  Feb 28, '19  N/A 
Michael Cherny ISI Group Sell   Feb 27, '18     77.00  Feb 27, '19  N/A 
Anthony Vendetti Maxim Group Buy   Feb 26, '18     87.00  Feb 26, '19  N/A 
George Hill Citi Buy   Jan 31, '18     98.00  Jan 31, '19  N/A 
Lisa Gill JPMorgan Buy   Dec 19, '17     85.00  Dec 19, '18  N/A 
Brian Tanquilut Jefferies & Co. Buy   Dec 15, '17     80.00  Dec 15, '18  N/A 
Eric Coldwell Robert W. Baird & Co., Inc. Buy   Dec 15, '17     81.00  Dec 15, '18  N/A 
Anthony Vendetti Maxim Group Buy   Dec 14, '17     87.00  Dec 14, '18  N/A 
Anthony Vendetti Maxim Group Buy   Oct 09, '17     78.00  Oct 09, '18  N/A 
Brian Tanquilut Jefferies & Co. Buy   Aug 29, '17     72.00  Aug 29, '18  N/A 
Anthony Vendetti Maxim Group Buy   Jul 18, '17     78.00  Jul 18, '18  N/A 
Robert Willoughby BofA Merrill Lynch Buy   Jul 12, '17     85.00  Jul 12, '18  N/A 
David Windley Jefferies & Co. Buy   Jul 07, '17     67.00  Jul 07, '18  N/A 
Brian Tanquilut Jefferies & Co. Buy   May 26, '17     67.00  May 26, '18  N/A 
Ricky Goldwasser Morgan Stanley Sell   Apr 26, '17     52.00  Apr 26, '18  N/A 
Charles Rhyee Cowen And Company Buy   Apr 04, '17     90.00  Apr 04, '18  N/A 
David Larsen Leerink Swann Llc Buy   Mar 07, '17       Mar 07, '18  N/A 
Brian Tanquilut Jefferies & Co. Buy   Oct 28, '16     88.00  Oct 28, '17  N/A 
Brian Tanquilut Jefferies & Co. Buy   Aug 29, '16     88.00  Aug 29, '17  N/A 
< previous1234